Has anyone used Selpercatinib for RET+ NSCLC?
Community Member
a day agoNSCLC I was diagnosed in January, had surgery in March, completed 30 days radiation and will complete 4 doses of chemo tomorrow. My oncologist wants to include 3 years of Selpercatinib, which is a relatively new RET inhibitor and treats my exact mutation, as a maintenance therapy. Curious if thoughts and results using this treatment?
Community Member
a day agoSelpercatinib has shown promising results in clinical trials for RET-positive NSCLC, and it's encouraging that your oncologist is considering a targeted therapy that specifically matches your tumor's genetic profile. This community is a great place to connect with others who may have experience with RET inhibitors - sharing experiences and questions about newer treatments can be really valuable as these therapies become more widely used.
New to the community?
Create an account to connect with others navigating cancer.
Related Questions
- What should I ask my doctor about EGFR-positive lung cancer treatment?
- Has anyone tried the Pfizer PADL1NK 005 clinical trial for lung cancer?
- My Cancer Journey: From Diagnosis to Clinical Trial
- Can lung cancer patients share their story in paid research studies?
- What to expect after lung cancer surgery: re-resection vs chemo options?
- How do stage IV lung cancer treatment options differ from earlier stages?
- Has anyone used Selpercatinib for RET+ NSCLC?
- Does lung surgery pain ever get better after 2 years?
© 2026 Outcomes4Me Inc. All rights reserved.